ETF Holdings Breakdown of BMEA

News associated with BMEA

Biomea Fusion, Inc. (NASDAQ:BMEA) Shares Bought by Renaissance Technologies LLC

Renaissance Technologies LLC boosted its holdings in Biomea Fusion, Inc. (NASDAQ:BMEA – Free Report) by 317.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 343,732 shares of the company’s stock after buying an additional 261,432 shares during the period. Renaissance Technologies LLC owned approximately 0.95% of Biomea […] - 2025-04-29 08:05:00

Biomea Fusion, Inc. (NASDAQ:BMEA) Receives $23.91 Average Target Price from Analysts

Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) have been given a consensus recommendation of “Buy” by the thirteen research firms that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, nine have given a buy recommendation and two have issued a […] - 2025-04-24 05:28:53

Federated Hermes Inc. Invests $463,000 in Biomea Fusion, Inc. (NASDAQ:BMEA)

Federated Hermes Inc. bought a new stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Free Report) in the fourth quarter, Holdings Channel reports. The fund bought 119,259 shares of the company’s stock, valued at approximately $463,000. Several other hedge funds also recently added to or reduced their stakes in BMEA. Wells Fargo & Company […] - 2025-04-18 07:57:03

Wellington Management Group LLP Invests $317,000 in Biomea Fusion, Inc. (NASDAQ:BMEA)

Wellington Management Group LLP purchased a new stake in shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor purchased 81,759 shares of the company’s stock, valued at approximately $317,000. A number of other institutional investors also recently modified their holdings of BMEA. Barclays PLC raised […] - 2025-04-15 07:48:53

Reviewing Biomea Fusion (NASDAQ:BMEA) & Tango Therapeutics (NASDAQ:TNGX)

Biomea Fusion (NASDAQ:BMEA – Get Free Report) and Tango Therapeutics (NASDAQ:TNGX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation and institutional ownership. Valuation and Earnings This table compares Biomea […] - 2025-04-09 05:22:50

Analyzing Biomea Fusion (NASDAQ:BMEA) and Pliant Therapeutics (NASDAQ:PLRX)

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report) and Biomea Fusion (NASDAQ:BMEA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Valuation and Earnings This table compares Pliant […] - 2025-03-28 06:08:52

Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of “Buy” from Analysts

Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) have earned a consensus rating of “Buy” from the thirteen ratings firms that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation, nine have assigned a buy recommendation and two have given a strong buy recommendation […] - 2025-03-27 07:10:58

Biomea Fusion, Inc. (NASDAQ:BMEA) Receives $39.36 Average PT from Brokerages

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) has earned an average rating of “Buy” from the thirteen ratings firms that are covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the […] - 2025-03-05 06:20:51

Biomea Fusion, Inc. (NASDAQ:BMEA) Short Interest Up 6.2% in January

Biomea Fusion, Inc. (NASDAQ:BMEA – Get Free Report) was the recipient of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 11,540,000 shares, a growth of 6.2% from the December 31st total of 10,870,000 shares. Based on an average trading volume of 891,600 shares, […] - 2025-02-03 06:10:56

BMEA institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	17,604	USD 30,807
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	17,604	USD 30,807 2.9%
Total =		35,208	USD 61,614

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer